Finith E. Jernigan
Impact in
- Toxicology top 10%
-
- Synthesis and biological activity
- Click Chemistry and Applications
- Synthesis and Biological Evaluation
- Synthesis and Characterization of Heterocyclic Compounds
Papers in
-
- CRISPR and Genetic Engineering 1
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Lijun Sun (7 shared papers)David S. Lawrence (4 shared papers)Yiqiang Wang (3 shared papers)Bruce R. Zetter (2 shared papers)Jun‐ichi Hanai (2 shared papers)Vikas P. Sukhatme (2 shared papers)Richard S. Agnes (1 shared paper)Ivy Chung (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)European Journal of Medicinal Chemistry (2 papers)Future Medicinal Chemistry (1 paper)Chemical Communications (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesMalaysiaSwitzerland
In The Last Decade
Finith E. Jernigan
14 papers receiving 424 citations
Peers
Comparison fields: 5 of 73
- Toxicology 23
- Organic Chemistry 134
- Cancer Research 57
- Biological Psychiatry 8
- Molecular Biology 208
Countries citing papers authored by Finith E. Jernigan
This map shows the geographic impact of Finith E. Jernigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finith E. Jernigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finith E. Jernigan more than expected).
Fields of papers citing papers by Finith E. Jernigan
This network shows the impact of papers produced by Finith E. Jernigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finith E. Jernigan. The network helps show where Finith E. Jernigan may publish in the future.
Co-authors
The 25 scholars most cited alongside Finith E. Jernigan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 100 | |
| 2 | 2016 | 78 | |
| 3 | 2010 | 66 | |
| 4 | 2020 | 53 | |
| 5 | 2014 | 36 | |
| 6 | 2016 | 26 | |
| 7 | 2017 | 20 | |
| 8 | 2021 | 18 | |
| 9 | 2016 | 15 | |
| 10 | 2015 | 12 | |
| 11 | 2013 | 10 | |
| 12 | 2019 | 6 | |
| 13 | 2014 | 4 | |
| 14 | 2017 | 3 |
About Finith E. Jernigan
Finith E. Jernigan is a scholar working on Cell Biology, Molecular Biology, Cancer Research, Pathology and Forensic Medicine and Computational Theory and Mathematics, having authored 14 papers that have together received 447 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (2 papers), Photochromic and Fluorescence Chemistry (2 papers), Cancer Mechanisms and Therapy (2 papers), Synthesis and biological activity (2 papers), Cancer, Lipids, and Metabolism (2 papers), Photoreceptor and optogenetics research (2 papers), CRISPR and Genetic Engineering (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Toxicology (23 citations), Organic Chemistry (134 citations), Cancer Research (57 citations), Biological Psychiatry (8 citations) and Molecular Biology (208 citations). Finith E. Jernigan has collaborated with scholars based in United States, Malaysia and Switzerland. Frequent co-authors include Lijun Sun, David S. Lawrence, Yiqiang Wang, Bruce R. Zetter, Jun‐ichi Hanai, Vikas P. Sukhatme, Richard S. Agnes, Ivy Chung, Vyas Sharma and Jennifer R. Shell. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Future Medicinal Chemistry, Chemical Communications and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.